TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial

Background: Experimental studies suggest that angiotensin II plays a central role in the pathogenesis of abdominal aortic aneurysm. This trial aims to evaluate the efficacy of the angiotensin receptor blocker telmisartan in limiting the progression of abdominal aortic aneurysm. Methods/Design: Telmi...

Full description

Bibliographic Details
Main Authors:	Morris, D., Cunningham, M., Ahimastos, A., Kingwell, B., Pappas, E., Bourke, M., Reid, Christopher, Stijnen, T., Dalman, R., Aalami, O., Lindeman, J., Norman, P., Walker, P., Fitridge, R., Bourke, B., Dear, A., Pinchbeck, J., Jaeggi, R., Golledge, J.
Format:	Journal Article
Published:	BioMed Central Ltd. 2015
Online Access:	http://hdl.handle.net/20.500.11937/38418

Internet

http://hdl.handle.net/20.500.11937/38418

TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial

Internet

Similar Items